ELEANOR YIP: Open Payments
NPI 1407632508 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 34 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $585 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $231 |
| Merck Sharp & Dohme LLC | 6 | $137 |
| PFIZER INC. | 4 | $81 |
| BridgeBio Pharma, Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $56 |
| Kestra Medical Technology Services, Inc. | 2 | $54 |
| SCPHARMACEUTICALS INC. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| CVRx, Inc. | 1 | $36 |
Products named: CARDIOMEMS, VERQUVO, Attruby, LEQVIO, AMVUTTRA, Assure WCD, VYNDAQEL, FUROSCIX.
Industry payments across NY — which companies pay providers there.
